Inhibrx Biosciences shares owned by Citigroup
Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Inhibrx Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Inhibrx Biosciences held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Inhibrx Biosciences by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $4.2M | 63k | 67.23 |
| 2025-03-31 | $119k | 8.5k | 13.99 |
| 2024-12-31 | $154k | 10k | 15.40 |
| 2024-09-30 | $146k | 9.3k | 15.66 |
| 2024-06-30 | $59k | 4.2k | 14.17 |